UK markets open in 5 hours

Keros Therapeutics, Inc. (KROS)

NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
48.48-0.68 (-1.38%)
At close: 04:00PM EDT
48.48 0.00 (0.00%)
After hours: 04:02PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-160,302
-152,992
-104,679
-58,744
-45,361
Depreciation & amortisation
925
815
674
378
278
Stock-based compensation
31,146
28,763
18,682
11,722
4,097
Change in working capital
-7,971
-2,650
14,308
-16,070
2,275
Accounts receivable
-226
-143
18,000
-18,000
0
Accounts payable
315
1,614
-408
1,485
61
Other working capital
-137,181
-126,972
-71,303
-63,172
-37,188
Other non-cash items
1,369
1,552
941
520
1,817
Net cash provided by operating activities
-134,833
-124,508
-70,062
-62,148
-36,894
Cash flows from investing activities
Investments in property, plant and equipment
-2,348
-2,464
-1,241
-1,024
-294
Net cash used for investing activities
-2,348
-2,464
-1,241
-1,024
-294
Cash flows from financing activities
Common stock issued
219,857
175,825
119,578
28,171
243,202
Other financing activities
-
-94
-87
-
-3,196
Net cash used provided by (used for) financing activities
228,080
178,956
120,309
28,550
296,044
Net change in cash
90,899
51,984
49,006
-34,622
258,856
Cash at beginning of period
352,756
280,375
231,369
265,991
7,135
Cash at end of period
443,655
332,359
280,375
231,369
265,991
Free cash flow
Operating cash flow
-134,833
-124,508
-70,062
-62,148
-36,894
Capital expenditure
-2,348
-2,464
-1,241
-1,024
-294
Free cash flow
-137,181
-126,972
-71,303
-63,172
-37,188